<DOC>
	<DOC>NCT00127270</DOC>
	<brief_summary>This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.</brief_summary>
	<brief_title>Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Symptoms of overactive bladder Capable of independent toileting and completing a micturition diary Able to comprehend English and follow study procedures and instructions Post void residual &gt; 100ml/sec Urine flow rate (Qmax) &lt;10ml/sec for males only Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>OAB</keyword>
	<keyword>Overactive Bladder</keyword>
	<keyword>Bladder hyperactivity</keyword>
	<keyword>Urge Incontinence</keyword>
	<keyword>Incontinence</keyword>
	<keyword>Bladder</keyword>
</DOC>